Inhibitory effect of local ischaemic preconditioning in total body irradiated rats

Teratogenesis Carcinogenesis and Mutagenesis

Volumn , Issue SUPPL. 1, 2003, Pages 195-205

  Walichiewicz, Piotr ^a   Przybyszewski, Waldemar M ^a   Jochem, Jerzy ^b   Widel, Maria ^a   Koterbicka, Aleksandra ^a   Snietura, Miroslaw ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bone marrow polychromatic erythrocytes; Gamma rays; Ischaemic preconditioning; Lipid peroxidation TBA RS; Small intestine crypts; Triglycerides; Uric acid

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; BONE MARROW CELL; CONDITIONING; CONFERENCE PAPER; ENDOTHELIUM CELL; ERYTHROCYTE MEMBRANE; GAMMA RADIATION; GROWTH INHIBITION; INTESTINE CRYPT; ISCHEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RAT; TISSUE OXYGENATION; TUMOR GROWTH; WHOLE BODY RADIATION;

ANIMALIA;

EID: 0037288317     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/tcm.10074     Document Type: Conference Paper

References (27)

1. Withers HR. The four R's of radiotherapy. Adv Radiat Biol 1975;5:241-247.
2. Steel GG, McMillan TJ, Peacock JH. The 5 Rs of radiobiology. Int J Radiat Biol 1989;56:1045-1048.
3. Withers HR, Peters LJ. Biological aspects of radiation therapy. In: Fletcher GH, editor. Textbook of radiotherapy, 3rd ed. Philadelphia: Lea and Febiger; 1980. p 250-280.
4. Kaanders JH, Pop LA, Marres HA, et al. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol 1998;48:115-122.
5. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
6. Liebman J, deLuca AM, Coffin D, et al. In vivo radiation protection by nitric oxide modulation. Cancer Res 1994:54:3365-3368.
7. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemic a delay of lethal cell injury in ischaemic myocardium. Circulation 1986;74:1124-1136.
8. Pang CJ, Yang RZ, Zhoung A, et al. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 1995;29:782-786.
9. Lee HT, Shroeder A, Shah PM, et al. Preconditioning with ischaemia or adenosine protects skeletal muscle from ischaemic tissue reperfusion injury. J Surg Respir 1996;63:29-34.
10. Hardy KJ, McClure DN, Subwongcharoen S. Ischaemic preconditioning of the liver: a preliminary study. Austral NZ J Surg 1996;66:707-710.
11. Matsushima K, Hakim AM. Transient forebrain ischaemia protects against subsequent focal cerebral ischaemia without changing cerebral perfusion. Stroke 1995;26:1047-1052.
12. Tsuruma T, Yagihashi A, Matsumo T. Introduction of warm ischaemic tolerance following preconditioning of the small intestine. Transplant Proc 1996;28:1298-1299.
13. Islam CF, Matkie RT, Dinneen MD, et al. Ischaemia-reperfusion injury in the rat kidney: the effects of preconditioning. Br J Urol 1997;79:842-847.
14. Gho BC, Shoemaker RG, van den Doel MA, et al. Myocardial protection by brief ischaemia in noncardiac tissue. Circulation 1996;94:2193-2200.
15. Murry CE, Jennings RR, Reiner KA. New insights into potential mechanism of ischaemic preconditioning. Circulation 1991;84:44.
16. Asakawa T, Matsushita S. Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 1980;15:137-140.
17. Chlopicki S, Lomnicka M, Gryglewski RJ. Reversal of postischaemic suppression of coronary function in perfused guinea pig heart: by ischaemic preconditioning. J Physiol Pharmacol 1999;50:605-615.
18. Parrat JR. Protection of the heart by ischaemic preconditioning mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 1994;15:19-25.
19. Stark G. The effect of ionizing radiation on lipid membranes. Biochem Biophys Acta 1991;1071:103-122.
20. Watson BD. Usual and unusual methods for detecting of lipid peroxides as indicators of tissue injury in cerebral ischaemia: What is appropriate and useful? Cell Mol Neurobiol 1998;18:581-598.
21. Esterbauer H. Estimation of peroxidative damage. Pathol Biol 1996;44:25-28.
22. Rubbo H, Darley-Usmar V, Freeman BA. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 1996;9:809-820.
23. Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. European Journal Clinical Investigation 1991;21:361-374.
24. Graham A, Hogg N, Kalyanaraman B, O'Leary VJ, Darley-Usmar V, Moncada S. Peroxynitrite modification of low density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett 1993;330:181-185.
25. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides on antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci 1981;78:6858-6862.
26. Becker BF, Reinholz N, Ozcelik T, Leipert B, Gerlach E. Uric acid as radical scavenger and antioxidant in the heart. Pflug Arch 1989;415:127-135.
27. Dewit L, Oussoren Y, Bartelink H. The effects of cis-diamminedichloroplatinum (II) and radiation on the proliferation kinetics of mouse duodenal crypt cells and on a partially synchronized crypt cell population. Int J Radiat Oncol Biol Phys 1986;12:1977-1985.